Skip to main content
logo
Actinium Pharmaceuticals, Inc. (ATNM)
NYSEAMERICAN: ATNM · Real-Time Price · USD
1.220
+0.030 (2.52%)
At close: Sep 18, 2026, 4:00 PM EDT
1.250
+0.030 (2.46%)
After-hours: Sep 18, 2026, 8:00 PM EDT

Actinium Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Other Revenue
35.090.09-0.081.031.14
Revenue
35.090.09-0.081.031.14
Revenue Growth
----92.14%-9.96%-
Gross Profit
35.090.09-0.081.031.14
Selling, General & Admin
7.4115.2112.0813.33128.08
Research & Development
18.1221.1230.0538.6723.1418.03
Operating Expenses
25.5336.3442.125235.1326.11
Operating Income
9.56-36.25-42.12-51.92-34.1-24.96
Interest & Investment Income
1.752.363.883.11.090.19
Pretax Income
11.31-33.89-38.24-48.82-33.02-24.77
Net Income
11.31-33.89-38.24-48.82-33.02-24.77
Net Income to Common
11.31-33.89-38.24-48.82-33.02-24.77
Net Income Growth
------
Shares Outstanding (Basic)
313130272421
Shares Outstanding (Diluted)
313130272421
Shares Change
0.28%3.74%13.03%10.20%17.37%69.51%
EPS (Basic)
0.36-1.09-1.27-1.83-1.37-1.20
EPS (Diluted)
0.36-1.09-1.27-1.83-1.37-1.20
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-23.25-24.68-33.08-47.498.28-21
Free Cash Flow Per Share
-0.74-0.79-1.10-1.780.34-1.02
Gross Margin
100.00%100.00%-100.00%100.00%100.00%
Operating Margin
27.23%-40274.44%--64098.76%-3311.07%-2182.17%
Profit Margin
32.23%-37652.22%--60269.14%-3205.53%-2165.56%
Free Cash Flow Margin
-66.25%-27426.67%--58627.16%803.69%-1835.58%
EBITDA
9.79-36.06-41.91-51.71-33.9-24.78
D&A For EBITDA
0.240.180.210.210.210.19
EBIT
9.56-36.25-42.12-51.92-34.1-24.96
Revenue as Reported
35.090.09-0.081.031.14
SEC Filings: 10-K · 10-Q